BIO Commends CA Senate for passage of biosimilars bill.
Share:
Press Release Summary:
In his statement regarding passage of Senate Bill 598, BIO President and CEO Jim Greenwood commended California's Assembly and Senate for "overwhelmingly passing legislation that creates a pathway for the substitution of interchangeable biologic medicines." Greenwood also expressed support for this legislation and encouraged Governor Brown to sign this bill. "BIO is pleased," said Greenwood, "that the California Legislature passed this legislation and continues to put patients first."
Original Press Release:
California Passes Biosimilars Bill to Promote Access to Biologic Medicines
BIO Encourages Governor to Sign Bill
WASHINGTON -- Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today issued the following statement on the California Senate's passage of Senate Bill 598:
“I commend California's Assembly and Senate for overwhelmingly passing legislation that creates a pathway for the substitution of interchangeable biologic medicines.”
"I commend California's Assembly and Senate for overwhelmingly passing legislation that creates a pathway for the substitution of interchangeable biologic medicines.
"As the policies outlined in Senate Bill 598 align with BIO’s principles on biologic substitution, BIO supports this important legislation and encourages Governor Brown to sign the bill when it reaches his desk.
"BIO is pleased that the California Legislature passed this legislation and continues to put patients first."
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
Contacts
Biotechnology Industry Organization (BIO)
George Goodno, 202-962-6660
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech
